multipel sklerosmultipel skleros
skog_smaa.jpg
  
 banner_minsupport_stor.gif

 

prenumeration-mssidan2.gif

 

merck-logo.gif 

 

Denna information är avsedd för vårdpersonal.
Om Du inte är vårdpersonal vänligen klicka här.

Nationella riktlinjer för patientutbildning vid start och uppföljning av interferon beta/glatirameracetatbehandling

Referenslista Utskrift E-post
  1. Arborelius, E. and Upjohn, Varför gör dom inte som vi säger?? 1993, Partille: Upjohn.
  2. Barlow, J.H., A.P. Turner, and C.C. Wright, A randomized controlled study of the Arthritis Self- Management Programme in the UK. Health Educ Res, 2000. 15: p. 665–80.
  3. Fredette, S.L., A model for improving cancer patient education. Cancer Nurs, 1990. 13: p. 207–15.
  4. Holland, N., et al., Adherence to disease-modifying therapy in multiple sclerosis: Part II. Rehabil Nurs, 2001. 26: p. 221–6.
  5. Holland, N., et al., Adherence to disease-modifying therapy in multiple sclerosis: Part I. Rehabil Nurs, 2001. 26: p. 172–6.
  6. Keating, M.M. and P.L. Ostby, Education and self-management of interferon beta-1b therapy for multiple sclerosis. J Neurosci Nurs, 1996. 28: p. 350–2, 357–8.
  7. TheEuropeanMSNurseNetwork, The European MS Nursing Care Plan. 2001, Mississauga: IntraMedical Health Services.
  8. Cassidy, C.A., Using the transtheoretical model to facilitate behavior change in patients with chronic illness. J Am Acad Nurse Pract, 1999. 11: p. 281-7.
  9. Denis, L., et al., Long-term treatment optimization in individuals with multiple sclerosis using disease-modifying therapies: a nursing approach. J Neurosci Nurs, 2004. 36: p. 10–22.
  10. Fallsberg, M. and Apotekarsocieteten, Tankar om mediciner och medicinering : en kvalitativ analys bland människor med långvarig läkemedelsbehandling. 1991, Institutionen för pedagogik och psykologi Univ. ; Apotekarsocieteten: Linköping och Stockholm.
  11. Halper, J. and N. J. Holland, Comprehensive nursing care of multiple sclerosis. 1996, New York: Demos Vermande.
  12. Paterson, B., et al., Living with diabetes as a transformational experience. Qual Health Res,
  13. 9: p. 786–802.
  14. Klang Söderkvist, B., Patientundervisning. 2001, Lund: Studentlitteratur.
  15. Miller, N.H., et al., The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation, 1997. 95: p. 1085–90.
  16. Heyduk, L.J., Medication education: increasing patient compliance. J Psychosoc Nurs Ment Health Serv, 1991. 29: p. 32–5.
  17. Fraser, C., O. Hadjimichael, and T. Vollmer, Predictors of adherence to Copaxone therapy in individuals with relapsing-remitting multiple sclerosis. J Neurosci Nurs, 2001. 33: p. 231–9.
Senast uppdaterad ( 2007-11-21 )
 
< Föregående
Denne siden omhandler multippel sklerose Juridisk förklaring MSsidan.se är senast uppdaterad: 2012-04-11 15:04 Siden er om multippel sklerose
Design av Gandalf